Tag Archives: Dapagliflozin

Concord Pharma introduced new anti-diabetic Dapazin (Dapagliflozin)

A new Horizon has been opened for Diabetes treatment.  Concord Pharmaceuticals Ltd. proudly introduced the new oral antidiabetic drug Dapazin (Dapagliflozin), for the first time in Bangladesh which may reduce insulin dependency in millions of diabetic patients in the future. Concord Pharmaceuticals has launched US FDA Approved latest anti-diabetic drug …

Read More »